Clinician-facing artificial intelligence and guideline adherence: a structured narrative review of comparative and interventional evidence
Journal of Diabetes & Metabolic Disorders · 07.08.2026 · 25 (2)
DOI: 10.1007/s40200-026-02030-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 07.08.2026. Verfasst von Reyhaneh Kalantar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To synthesize empirical evidence on whether clinician-facing artificial intelligence (AI) tools improve clinical practice guideline adherence and whether AI-generated recommendations are concordant with physician decision-making.
Methods
We conducted a structured narrative review aligned with SANRA and informed by narrative synthesis guidance. PubMed/MEDLINE, Embase, Scopus, Web of Science, and Google Scholar were searched for studies published from January 2020 to May 2026; earlier directly relevant studies were identified through citation tracking. Eligible studies evaluated clinician-facing AI tools, guideline adherence or concordance outcomes, or physician-versus-AI recommendations. Preprints were considered separately as emerging evidence and were not included in the peer-reviewed core synthesis.
Results
Six peer-reviewed empirical studies met the core eligibility criteria. They included one real-world EHR-integrated pathway study, one NLP-based adherence measurement study, one randomized simulation trial of a decision-tree CDSS, and three AI-versus-physician comparative studies. Findings were most favorable for bounded tasks embedded in workflow or structured scenarios. Evidence was weaker for complex real-world decisions, and several studies did not evaluate patient outcomes. Three 2026 preprints were summarized separately as preliminary evidence.
Conclusion
Early evidence suggests that clinician-facing AI may support guideline-concordant care when applied to clearly defined decision tasks and integrated into clinical workflow. However, the evidence base remains small, heterogeneous, and largely indirect for diabetes care. Prospective cardiometabolic studies are needed to evaluate effectiveness, safety, usability, and patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, No. 10, Jalal-Al-Ahmad Ave, Tehran, 1411713119 Iran.
- Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Kalantar, R., Dodangeh, S., Khalagi, K., & Larijani, B. (2026). Clinician-facing artificial intelligence and guideline adherence: a structured narrative review of comparative and interventional evidence. Journal of Diabetes & Metabolic Disorders, 25(2). https://doi.org/10.1007/s40200-026-02030-2
Vancouver
Kalantar R, Dodangeh S, Khalagi K, Larijani B. Clinician-facing artificial intelligence and guideline adherence: a structured narrative review of comparative and interventional evidence. Journal of Diabetes & Metabolic Disorders. 2026;25(2). doi:10.1007/s40200-026-02030-2
BibTeX
@article{Kalantar2026,
author = {Kalantar, Reyhaneh and Dodangeh, Salimeh and Khalagi, Kazem and Larijani, Bagher},
title = {Clinician-facing artificial intelligence and guideline adherence: a structured narrative review of comparative and interventional evidence},
journal = {Journal of Diabetes & Metabolic Disorders},
year = {2026},
volume = {25},
number = {2},
doi = {10.1007/s40200-026-02030-2}
}
EUVIMED